myMedidata Registries

臨床試験は通常、一度に1つの試験を中心に設計されます。このアプローチでは、試験実施前の被験者募集や試験実施後のフォローアップなど、長期にわたる患者エンゲージメントを維持することが困難になります。

myMedidata Registriesは、試験前、試験中、試験後を通じて継続的な患者エンゲージメントをサポートする統合された患者レジストリおよびポータルであり、単一の試験を越えた継続性を可能にします。

概要資料ダウンロード
Video transcript: Clinical trials are vital to creating innovative medicines that save lives, and patients play a crucial role in making these trials successful. Patients are the true heroes, selflessly dedicating their time and energy to participate in clinical trials, all while managing their own health challenges and juggling the demands of everyday life. If these challenges weren't enough to deter them from participating, consider this: Patients are often unaware of clinical trials as a viable care option, restricting their health care choices. Moreover, the process of finding an appropriate trial involves navigating various resources, causing confusion about how to enroll or who to contact. And in the event that a patient manages to participate, once the trial is over, they're often left in the dark about outcomes, uncertain of its impact on their medical care and disconnected from future trials. This lack of information leaves them uncertain, missing out on opportunities to improve their health and wondering whether it was worth their time. For sponsors of the trial, all of these challenges impact patient recruitment and retention, increasing costs and reducing the chance of clinical trial success. In response, My Metadata Registries was developed by patients, for patients to address these challenges, engaging patients before they've considered joining a trial and supporting them after they've participated. Here's how it works. Allison is directed to a My Metadata Registry website by her healthcare provider, patient advocacy group, or through social media advertising. Here, she learns about the benefits of joining the registry and discovers specific study opportunities presented in easy to understand language and with useful information to help her decide if the study is right for her. By creating a MyMetadata lifetime account, she gains access to all clinical trial support, equipping her with the necessary tools to successfully complete her trials. After creating her account, she completes custom eligibility assessments for one or more trials. If she meets the criteria, she's referred to a trial site for further screening and enrollment. After successfully completing a trial, Allison is informed of trial outcomes and notified of future study opportunities. She's now empowered in her healthcare journey, bringing information back to her family and caregivers to decide on next steps. MyMetadataRegistries empowers patients with expanded health care choices, presenting clinical trial opportunities as an option. This benefits both patients and sponsors, mitigating recruitment and retention challenges by creating a community of empowered, research ready patients. Together, we continue to celebrate patients as the true heroes in advancing medical knowledge and improving patient care. Learn more at mymetadata dot com slash registry.

患者が学び、試験に参加するための場所を一つに

臨床試験の機会を調べ、長期にわたってつながりを維持できる、信頼できる単一の場所があれば、患者はより積極的に参加し、関与し続ける可能性が高くなります。myMedidata Registriesは、試験前後の患者エンゲージメントを容易にサポートします。

患者リーチの拡大
被験者募集期間の短縮
研究に参加可能な被験者グループの構築
患者の長期的な参加をサポート

単なるデータではなく、
患者との関係を構築

患者

試験開始前に、治験への参加準備が整った患者さんを特定

レジストリは、患者さんが臨床研究の機会について学び、参加内容を理解し、長期にわたってつながりを維持するための単一の場所を提供します。

可視性とコミュニケーションを向上させることで、患者さんが自身の意思で参加できるよう支援します。

ファクトシートをダウンロード
Video transcript: Clinical trials are vital to creating innovative medicines that save lives, and patients play a crucial role in making these trials successful. Patients are the true heroes, selflessly dedicating their time and energy to participate in clinical trials, all while managing their own health challenges and juggling the demands of everyday life. If these challenges weren't enough to deter them from participating, consider this: Patients are often unaware of clinical trials as a viable care option, restricting their health care choices. Moreover, the process of finding an appropriate trial involves navigating various resources, causing confusion about how to enroll or who to contact. And in the event that a patient manages to participate, once the trial is over, they're often left in the dark about outcomes, uncertain of its impact on their medical care and disconnected from future trials. This lack of information leaves them uncertain, missing out on opportunities to improve their health and wondering whether it was worth their time. For sponsors of the trial, all of these challenges impact patient recruitment and retention, increasing costs and reducing the chance of clinical trial success. In response, My Metadata Registries was developed by patients, for patients to address these challenges, engaging patients before they've considered joining a trial and supporting them after they've participated. Here's how it works. Allison is directed to a My Metadata Registry website by her healthcare provider, patient advocacy group, or through social media advertising. Here, she learns about the benefits of joining the registry and discovers specific study opportunities presented in easy to understand language and with useful information to help her decide if the study is right for her. By creating a MyMetadata lifetime account, she gains access to all clinical trial support, equipping her with the necessary tools to successfully complete her trials. After creating her account, she completes custom eligibility assessments for one or more trials. If she meets the criteria, she's referred to a trial site for further screening and enrollment. After successfully completing a trial, Allison is informed of trial outcomes and notified of future study opportunities. She's now empowered in her healthcare journey, bringing information back to her family and caregivers to decide on next steps. MyMetadataRegistries empowers patients with expanded health care choices, presenting clinical trial opportunities as an option. This benefits both patients and sponsors, mitigating recruitment and retention challenges by creating a community of empowered, research ready patients. Together, we continue to celebrate patients as the true heroes in advancing medical knowledge and improving patient care. Learn more at mymetadata dot com slash registry.
Video thumbnail

関連資料


より詳細なガイダンスや関連資料をご覧ください。

すべてのリソースを表示

よくあるご質問

はい。myMedidata Registriesは、患者の参加を単一の治験という取引から、治験前後のエンゲージメントアプローチへと拡大するように設計されています。これにより、治験依頼者は治験について患者と関わり、教育することができます。また、治験開始前に適格性のある
参加候補者のプールを構築し、治験終了後には将来の治験機会についてフォローアップすることが可能になります。

myMedidata Registriesは、治験開始前に治験依頼者の治験への参加に関心を示した患者のコミュニティを構築することで、被験者募集を加速させます。治験終了後も、教育を受け、権限を与えられた患者のこのプールを維持することで、治験依頼者は将来の臨床試験の機会に彼らを迅速にマッチングさせることができ、適格な参加者を見つけるために必要な労力とリソースを大幅に削減できます。

はい。myMedidata Registriesは、患者に簡単な質問票を提供し、その回答を用いて適格性を評価することができます。さらに、myMedidata Registriesは、Circuit Clinicalとの提携により提供されるリクルートメントコンシェルジュサービスであるMD Prescreenを提供しています。この機能強化により、資格を持つ看護師や医療専門家による追加の被験者事前スクリーニングと治験マッチングが提供され、患者、実施医療機関、治験依頼者にとっての被験者募集プロセスが改善されます。

はい。Medidata Diversity Programの一環として、myMedidata Registriesは、治験依頼者が十分に代表されていない患者集団を募集、エンゲージ、維持するのを支援します。コミュニティエンゲージメント機能と実施医療機関レベルの人口統計データを組み合わせることで、このプラットフォームは、臨床チームが多様性のある登録目標を達成し、規制ガイダンスを遵守できるようにします。

はい。Medidataは、顧客およびパートナー向けに、自己学習型と講師主導型の両方のコースを含む、さまざまなトレーニングオプションを提供しています。利用可能なコースの詳細やリソースへのアクセスについては、Medidata Global Education and Trainingのセクションをご覧ください。